Showing 36,902 results

Filters
Pharmaceutical industry

Bristol-Myers Squibb executive arrested on insider trading charges

Editor's pick
hepatitiscnewdrugs.blogspot.com
3 August 2012
New & experimental hepatitis C treatment

Medivir announces an interferon-free phase II combination trial of hepatitis C drugs TMC435 and daclatasvir to commence shortly

Editor's pick
Medivir
29 June 2012
Hepatitis B

Hepatitis B vaccine protects for 25 years: study

Editor's pick
Reuters
21 June 2012
New & experimental hepatitis C treatment

Bristol Hep C Trial Change Has Big Implications

Editor's pick
Pharmalot
21 June 2012
Hepatitis C treatment

Hep C Top Social Networks and Blogs

Editor's pick
HCV New Drugs Research
4 June 2012
Pharmaceutical industry

Vertex Goes From Bad Data To A Bad Promotion

Editor's pick
Pharmalot
1 June 2012
Cancer

Four Bad Actors Cause Most Infection-Related Cancer

Editor's pick
Medscape (requires registration)
11 May 2012
New & experimental hepatitis C treatment

Grading Hep C Stocks Exiting EASL - The future of hepatitis C therapy belongs to interferon-free regimens

Editor's pick
The Street
23 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

EASL-Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy

Editor's pick
HCV New Drugs Research
19 April 2012
New & experimental hepatitis C treatment

EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin

Editor's pick
HCV New Drugs Research
19 April 2012
New & experimental hepatitis C treatment

Treating Hepatitis C: Comorbidity of the Wallet

Editor's pick
BioPlus Specialty Pharmacy
17 April 2012
New & experimental hepatitis C treatment

Winners, Losers From EASL Hepatitis C Data Dump

Editor's pick
The Street
10 April 2012
Hepatitis C symptoms & diagnosis

Highest-Risk Individuals Missed by Current HCV Screening

Editor's pick
Medscape (requires registration)
3 April 2012
New & experimental hepatitis C treatment

Merck's hepatitis C drug wins UK cost endorsement

Editor's pick
HCV New Drugs Research
9 March 2012
New & experimental hepatitis C treatment

Hard-to-Treat Group Trips Up Hepatitis C Drug

Editor's pick
MedPage Today
18 February 2012
New & experimental hepatitis C treatment

Gilead, Vertex and the Mystery of Missing Hep C Patients

Editor's pick
The Street
13 February 2012
New & experimental hepatitis C treatment

Achillion's Hep C Pipeline Likely Can't Compete

Editor's pick
BioMed Reports
19 January 2012
Pharmaceutical industry

Merck Hepatitis C Drug May `Anchor' Future Worldwide Regimen

Editor's pick
Bloomberg
10 January 2012
Hepatitis C transmission & prevention

Hepatitis C vaccine: Oxford researchers' trial 'promising'

Editor's pick
BBC
4 January 2012
Hepatitis C treatment

Poor Liver Transplant Outcomes for HIV/HCV Coinfected Patients

Editor's pick
Medscape (requires free registration)
6 December 2011
New & experimental hepatitis C treatment

AASLD-Santaris Phase 2a Data of Miravirsen Shows Dose-Dependent, Prolonged Viral Reduction of 2-3 Logs HCV RNA After Four-Week

Editor's pick
Santaris press release
5 November 2011
New & experimental hepatitis C treatment

Abbott says hepatitis C combo may be a blockbuster

Editor's pick
Reuters
21 October 2011
New & experimental hepatitis C treatment

Interim Phase IIb Data for Merck's VICTRELIS™ (boceprevir) in Patients Coinfected with Chronic Hepatitis C and HIV-1

Editor's pick
Market Watch (press release)
20 October 2011